{"id":"tp-40672","type":"article-newspaper","title":"Agenus Reports 72% Pathologic Complete Response in dMMR Colon Cancer Cohort","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/40672","datePublished":"2026-10-25T21:13:25.000Z","dateModified":"2026-10-25T21:13:25.000Z","language":"en","abstract":"The 18-patient Phase 2 cohort also met the study’s primary major pathologic response measure in 83% of patients.","section":"Business","references":[]}